Health Care & Life Sciences » Pharmaceuticals | Guizhou Xinbang Pharmaceutical Co. Ltd.

Guizhou Xinbang Pharmaceutical Co. Ltd. | Mutual Funds

Mutual Funds that own Guizhou Xinbang Pharmaceutical Co. Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
8,300,019
0.83%
-8,890,349
0.34%
12/31/2017
7,902,229
0.79%
0
0.08%
12/31/2017
China Universal Advantage Select Fund
4,500,000
0.45%
-2,600,000
1.4%
12/31/2017
Nanfang CSI 500 ETF
3,605,066
0.36%
-1,003,614
0.15%
12/31/2017
2,576,050
0.26%
2,576,050
1.2%
12/31/2015
2,160,150
0.22%
-1,843,734
0.39%
12/31/2017
Vanguard Emerging Markets Stock Index Fund
1,840,931
0.18%
0
0%
07/31/2018
1,834,515
0.18%
92,200
0.72%
12/31/2017
1,519,861
0.15%
1,519,861
0.24%
12/31/2017
UBS SDIC Core Companies Equity Fund
1,500,000
0.15%
1,500,000
0.87%
12/31/2017

About Guizhou Xinbang Pharmaceutical Co.

View Profile
Address
6/F, Garden No. 1, Kekai
Guiyang Guizhou 550018
China
Employees -
Website http://www.xinbang.com
Updated 07/08/2019
Guizhou Xinbang Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical products. Its business segments include pharmaceutical production and development, medical services, and medicine distribution sectors. Its products include medicines for cardiovascular and cerebrovascular, digestive system, endocrine, blood system, and urinary system diseases.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.